2 verified Pharmaceutical Formulation specialists

Pharmaceutical Formulation Assignment Help & Online Tutoring

In short: pharmaceutical formulation turns an active ingredient into a dosage form that is stable, accurately dosed and acceptable to the patient. FLN Tutors (Freelancer Network) offers one-to-one help with dosage forms, excipients, dissolution and stability, explained step by step. Matched to a verified specialist who knows your course, your university's marking criteria, and your deadline.

100% ConfidentialFree RevisionsPlagiarism-Free
150+
Topics covered
2
Pharmaceutical Formulation specialists

Online Pharmaceutical Formulation tutoring

FLN offers one-to-one online Pharmaceutical Formulation tutoring with verified subject specialists. Sessions focus on core theory, clinical application and exam preparation, including Preformulation Studies, Dosage Form Design, Excipients and Tablet Formulation, using your own course material, so you understand the subject and can apply it yourself.

Last updated

Levels we tutor

  • Undergraduate
  • Master's
  • PhD

What is pharmaceutical formulation?

Formulation is the work of turning an active pharmaceutical ingredient into a product a patient can actually use. The active substance alone is rarely usable: it may be a tiny quantity, poorly soluble, bitter, unstable in light or moisture, or impossible to dose accurately.

The formulation must deliver the right dose reliably, keep the drug stable for its shelf life, release it where and when intended, be manufacturable at scale, and be acceptable enough that patients take it.

Formulation applies the physical chemistry covered in pharmaceutics: solubility and its pH dependence, dissolution rate, partitioning, rheology and degradation kinetics all decide what a workable formulation can look like.

This page supports coursework. It is not a guide to preparing or using any medicine.

What is pharmaceutical formulation help?

It is one-to-one academic support from a pharmaceutics tutor who explains preformulation, dosage form design, excipients, manufacturing, quality control and stability, works through calculations and gives feedback on lab reports and assignments.

What you needBest optionWhat you get
Regular lessons through a pharmaceutics or formulation moduleLive one-to-one tutoringPrinciples and examples explained
Calculations or questions you are stuck onHomework helpStep-by-step workings
A graded formulation report or projectAssignment helpGuidance on justification and structure within your university's rules

Get a free pharmaceutical formulation quote.

Pharmaceutical formulation at a glance: key facts

A revision table for formulation coursework. It is educational only: it explains how products are designed and tested, not how any medicine should be used. Practice maths for exams only. Not clinical guidance; always follow your local protocol and prescriber.

ItemKey fact
DefinitionCombining an active pharmaceutical ingredient with excipients and a manufacturing process to make a stable, accurately dosed, usable dosage form
PreformulationSolubility, pKa, partition coefficient, polymorphism, particle size and stability of the active, measured before the dosage form is chosen
Main dosage formsTablets, capsules, oral liquids, semisolids, injections, inhalations and transdermal systems
Excipient rolesDiluent, binder, disintegrant, lubricant, glidant, coating, preservative and solubiliser
Powder flow indicesCarr's index = (tapped − bulk density) ÷ tapped density × 100; Hausner ratio = tapped ÷ bulk density
Shelf-life kineticsFirst order: t90 = 0.105 ÷ k
Profile comparisonSimilarity factor f2 of 50 or more suggests similar dissolution profiles
Key guidelinesICH Q1A(R2) stability testing; ICH Q8(R2) pharmaceutical development
Typical course levelMPharm, PharmD, BPharm and pharmaceutical science degrees; MSc pharmaceutics
Assessment typesLab reports, formulation design projects, calculation tests, OSCE-style practicals and exams

Most lost marks come from choosing a dosage form without using the drug's own properties to justify it.

Preformulation: the questions asked first

Before a dosage form is chosen, the active substance is characterised:

  • Solubility, including how it varies with pH, which largely determines absorption.
  • pKa, since ionisation drives both solubility and permeability.
  • Partition coefficient, indicating lipophilicity.
  • Crystal form and polymorphism, because different polymorphs can differ in solubility and stability.
  • Particle size and surface area, affecting dissolution rate and flow.
  • Stability to heat, light, moisture, oxidation and pH.
  • Compatibility with candidate excipients.

Skipping to a formulation without this characterisation is the structural error in weak assignments. Every later decision follows from these properties.

Dosage forms compared

FormAdvantagesLimitations
TabletAccurate dose, cheap, stable, portableSwallowing difficulty, slower onset
CapsuleMasks taste, easier to swallowCostlier, less tamper-evident
Oral liquidFlexible dose, suits childrenBulky, often less stable
Topical and transdermalLocal effect or avoids first passLimited to suitable molecules
InjectionRapid, complete, bypasses the gutInvasive, sterility essential
InhalationDirect to lung, small doseDepends on technique and device
SuppositoryUseful when swallowing is impossiblePoor acceptability, variable absorption

A formulation answer should justify the form from the drug's properties and the patient group, not simply describe the form chosen.

Excipients and what each is for

ClassFunctionWhy it matters
Diluent or fillerBulks out a small doseA 1 mg dose cannot be handled alone
BinderHolds the tablet togetherToo little causes crumbling, too much slows release
DisintegrantBreaks the tablet apartWithout it, dissolution is very slow
LubricantPrevents sticking to toolingExcess can retard dissolution
GlidantImproves powder flowPoor flow causes weight variation
SurfactantAids wettingImportant for poorly soluble drugs
PreservativePrevents microbial growthNeeded in most multi-dose liquids
CoatingTaste masking, protection, modified releaseEnteric coats protect acid-labile drugs

Excipients are not inert filler: each is there for a reason, and the quantity matters. Over-lubrication slowing dissolution is a classic examined example of a helpful excipient causing a problem.

Granulation and tablet manufacturing methods

Most tablets are made from powders that must flow well and compress into a strong compact. Three main routes are taught:

MethodHow it worksAdvantagesLimitations
Wet granulationPowders are mixed with a binder solution, granulated, dried and sizedImproves flow, content uniformity and compressibilityMore steps; heat and moisture can harm sensitive drugs
Dry granulation (slugging or roller compaction)Powders are compacted, then milled into granules without liquidSuits moisture- or heat-sensitive drugsCan produce more fines; less effective for some powders
Direct compressionThe blend is compressed without granulationFewest steps, lowest costNeeds excipients with good flow and compressibility; segregation risk

After granulation, a lubricant is usually blended in last and briefly, then the blend is compressed and, where needed, coated. In assignments, justify the method from the drug's dose, stability and powder properties rather than naming one by default.

Worked example: assessing powder flow

Good flow is essential for uniform die filling and consistent tablet weight. Two simple indices compare bulk and tapped density:

  • Carr's compressibility index = (tapped density − bulk density) ÷ tapped density × 100
  • Hausner ratio = tapped density ÷ bulk density

Example. A blend has a bulk density of 0.45 g/mL and a tapped density of 0.56 g/mL.

MeasureWorkingResult
Carr's index(0.56 − 0.45) ÷ 0.56 × 10019.6%
Hausner ratio0.56 ÷ 0.451.24

On the commonly used pharmacopoeial scale, a Carr's index of about 16–20% and a Hausner ratio of about 1.19–1.25 indicate fair flow. Flow could be improved by granulation, adding a glidant or increasing particle size. Angle of repose is a third measure often reported alongside these indices.

Worked example: dose, dilution and a tablet batch

Children's suspension. A syrup contains 125 mg per 5 mL. A dose of 90 mg requires:

90 ÷ 125 × 5 = 3.6 mL

Dilution. 200 mL of a 5% w/v solution diluted to 500 mL gives:

(5% × 200) ÷ 500 = 2% w/v

Checking by mass: 5% of 200 mL is 10 g, and 10 g in 500 mL is 2% w/v. The two routes agree.

Batch calculation. A tablet contains 50 mg of drug at 20% of tablet weight, so each tablet weighs 50 ÷ 0.20 = 250 mg. A batch of 100,000 tablets therefore needs 100,000 × 0.050 g = 5 kg of active and 100,000 × 0.250 g = 25 kg of total blend, of which 20 kg is excipients.

Always state units and check by a second route. A misplaced decimal in a formulation calculation is a patient safety issue, not just a lost mark.

Tablet manufacturing problems

ProblemAppearanceUsual cause
CappingTop separates as a capAir entrapment, over-compression
LaminationSplits into horizontal layersSimilar causes to capping
Sticking and pickingMaterial adheres to punch facesInsufficient lubricant, excess moisture
MottlingUneven colourPoor mixing, migration during drying
Weight variationInconsistent tablet massPoor powder flow, segregation
ChippingEdges break awayLow binder, worn tooling

These are routinely examined as cause-and-remedy pairs. Learn the mechanism rather than the list: capping comes from air trapped in the compact, so the remedies all address air removal or compression force.

Quality control tests for tablets

TestWhat it checks
Weight variation or uniformity of massConsistency of tablet weight
Content uniformityEach tablet contains the correct amount of drug
Hardness (crushing strength)Mechanical strength
FriabilityResistance to chipping and abrasion
DisintegrationTime to break up in the test medium
DissolutionRate and extent of drug release
Assay and impuritiesDrug content and degradation products

Example: friability. A sample of tablets weighing 6.500 g before the test weighs 6.452 g after tumbling.

StepWorkingResult
Weight loss(6.500 − 6.452) ÷ 6.500 × 1000.74%

A maximum mean weight loss of not more than 1% is a commonly used pharmacopoeial limit, so this batch passes. Always quote the exact limits and method from the pharmacopoeia your course follows.

Dissolution, bioavailability and stability

Dissolution testing measures how fast the drug goes into solution under defined conditions. It matters because a drug cannot be absorbed until dissolved, so for poorly soluble drugs dissolution is the rate-limiting step and the formulation controls absorption.

Bioavailability is the fraction of an administered dose reaching the systemic circulation unchanged. It is reduced by incomplete dissolution, poor permeability, and first-pass metabolism.

Stability is assessed under controlled temperature and humidity conditions, both in real time and accelerated, to set a shelf life and storage statement. Degradation routes include hydrolysis, oxidation, photolysis and interaction with an excipient or the container.

The standard pharmacopoeial and regulatory requirements differ between regions, so cite the pharmacopoeia or guideline your course specifies rather than assuming one.

Worked example: comparing dissolution profiles with the f1 and f2 fit factors

When a formulation changes — a new excipient supplier, a different granulation route, a scale-up from pilot to production — you have to show the new product releases drug like the old one. Comparing the two curves by eye is not acceptable to a regulator. The standard tools are the difference factor f1 and the similarity factor f2, and they appear in FDA and EMA guidance on dissolution testing and biowaivers.

The formulas. With n time points, R for reference and T for test:

  • f1 = [ Σ|Rt − Tt| ÷ ΣRt ] × 100 — a percentage difference, so smaller is better, and the limit is f1 ≤ 15
  • f2 = 50 × log₁₀ { 100 ÷ √[ 1 + (1/n)Σ(Rt − Tt)² ] } — a similarity score out of 100, so bigger is better, and the limit is f2 ≥ 50

f2 rests on the mean squared difference, which is the design choice that matters: one badly deviating time point hurts f2 far more than several small ones, because squaring punishes outliers.

Choose the time points before you calculate. The reference profile is:

Time (min)153045607590
Reference % dissolved355874859296

Guidance allows only one measurement after 85% dissolution to be included. Here both 92% (75 min) and 96% (90 min) are above 85%, so the 90-minute point is dropped and five points remain. This is not a technicality to skip — beyond 85% both products are nearly fully dissolved, the differences shrink towards zero, and including those points inflates f2 artificially. A student who uses all six points gets a higher, friendlier number and loses the mark.

Test A — a minor process change.

Time (min)1530456075
Reference3558748592
Test A3052708391
Difference56421
Difference²25361641

Σ(R−T)² = 82, so (1/5)(82) = 16.40, and √(1 + 16.40) = 4.1713.

f2 = 50 × log₁₀(100 ÷ 4.1713) = 50 × log₁₀(23.973) = 50 × 1.37979 = 69.0

f1 = (5 + 6 + 4 + 2 + 1) ÷ 344 × 100 = 18 ÷ 344 × 100 = 5.23%

Both pass comfortably — f2 = 69 against a floor of 50, f1 = 5.2% against a ceiling of 15. The profiles are similar and the change is supportable.

Test B — a different granulation route.

Time (min)1530456075
Reference3558748592
Test B2240587283
Difference131816139
Difference²16932425616981

Σ(R−T)² = 999, so (1/5)(999) = 199.80, and √200.80 = 14.1704.

f2 = 50 × log₁₀(100 ÷ 14.1704) = 50 × log₁₀(7.0569) = 50 × 0.84858 = 42.4

f1 = 69 ÷ 344 × 100 = 20.06%

Both fail — f2 is below 50 and f1 is above 15. The two tests agree, which they usually do; when they disagree, f2 is the one regulators quote.

Read the shape, not just the verdict. Test B is slower at every single point and the gap is widest in the middle of the curve, peaking at 18% at 30 minutes. That pattern — slow early and mid-release, converging late — points at the granules rather than the drug: harder granules, a higher compression force, or a more hydrophobic binder distribution slowing wetting and disintegration. A profile that instead matched early and diverged late would point somewhere else entirely, usually at a solubility or sink-condition problem in the vessel.

Three conditions that must hold before either number means anything.

  • Same conditions for both profiles — same apparatus, speed, medium, volume and temperature. Comparing a test run in pH 6.8 phosphate buffer with a reference run in 0.1 M HCl produces an f2 value that is arithmetically correct and scientifically worthless.
  • At least 12 units per profile, with a coefficient of variation no more than 20% at the early time points and 10% later. f2 is calculated on mean values, so it hides variability completely; a test batch where individual tablets range from 40% to 95% at 45 minutes can still average into a passing f2.
  • At least three time points, excluding zero, and the same points for both profiles. Two points cannot describe a curve, and f2 on two points is not a defensible submission.

Finally, note what f2 does not do. It compares release in a beaker. It is evidence for a biowaiver only when the drug is highly soluble and the dosage form is immediate-release — a BCS Class I or III argument. For a poorly soluble Class II drug, similar dissolution in one medium does not establish bioequivalence, and the examiner's expected answer is that in vivo data may still be required.

Modified-release and sustained-release systems

Modified-release dosage forms change the timing or location of drug release compared with a conventional immediate-release form. Main types:

TypePurposeExamples of approach
Delayed releaseRelease after passing the stomachEnteric coatings that dissolve at higher pH
Sustained or extended releaseRelease over many hours to reduce dosing frequencyHydrophilic matrix tablets, coated pellets
Controlled releaseRelease at a near-constant rateOsmotic pump systems
Targeted releaseRelease at a particular siteColon-targeted coatings
MechanismHow it works
Matrix systemsDrug is dispersed in a polymer that swells, erodes or forms a gel, slowing diffusion
Reservoir (membrane) systemsA drug core is surrounded by a rate-controlling coat
Osmotic systemsWater enters through a semipermeable membrane and pushes drug out through a small orifice

Advantages include fewer doses and steadier plasma levels; limitations include dose dumping risk, higher cost and the need not to crush many products. Exam answers should link the system to the drug's half-life, dose and therapeutic needs.

Worked example: shelf life and stability testing

Many degradation reactions follow first-order kinetics, so the time for the drug content to fall to 90% of its initial value (t90, often used to set shelf life) is:

t90 = 0.105 ÷ k

Example. A drug degrades with a first-order rate constant of 0.0003 per day at the storage temperature.

StepWorkingResult
t900.105 ÷ 0.0003about 350 days

Stability programmes follow the ICH stability guideline (Q1A), which describes long-term testing (for example 25 °C and 60% relative humidity) and accelerated testing (for example 40 °C and 75% relative humidity for six months), with conditions depending on the climatic zone. The Arrhenius equation links the rate constant to temperature and is used to interpret accelerated data. Cite the current guideline your course uses, because conditions vary for different zones and product types.

What is quality by design in formulation development?

Quality by design (QbD) is the systematic approach set out in the ICH Q8(R2) pharmaceutical development guideline: quality is built into the product through understanding, rather than tested in at the end. Final-year and master's assignments increasingly ask students to apply it to a formulation they have designed.

The QbD sequence.

StepQuestion it answersExample for an immediate-release tablet
Quality target product profile (QTPP)What must the product achieve for the patient?Oral tablet, rapid release, stable for the intended shelf life
Critical quality attributes (CQAs)Which measurable properties decide that?Assay, content uniformity, dissolution, hardness, impurities
Critical material attributesWhich ingredient properties affect the CQAs?Particle size of the active, lubricant grade, moisture content
Critical process parametersWhich process settings affect the CQAs?Granulation water, blending time, compression force
Design spaceWithin what ranges does quality hold?Combinations of compression force and lubricant level that still pass dissolution
Control strategyHow is quality kept inside the design space?In-process checks, specifications and process analytical technology

A percentage formula students can analyse. A wet-granulated tablet blend might be written as active 20%, lactose monohydrate 52%, microcrystalline cellulose 20%, povidone 3%, croscarmellose sodium 4% and magnesium stearate 1%. The parts add up to 100%. For a 10 kg trial batch that means 2 kg active, 5.2 kg lactose, 2 kg microcrystalline cellulose, 0.3 kg povidone, 0.4 kg croscarmellose sodium and 0.1 kg magnesium stearate.

A QbD answer would then ask which of these are critical. Magnesium stearate is a classic example: the share is small, but over-blending it can coat particles, slow wetting and lower dissolution, so blending time becomes a critical process parameter. Croscarmellose sodium controls disintegration, so its level links directly to the dissolution CQA.

Risk assessment tools. Ishikawa (fishbone) diagrams list possible causes; failure mode and effects analysis ranks them by severity, occurrence and detectability; a design of experiments then tests the high-risk factors together rather than one at a time. Showing that chain is what earns the marks.

Liquid and semisolid dosage forms

FormKey formulation issuesTypical excipients
SolutionsSolubility, pH, stability, taste, preservationCo-solvents, buffers, sweeteners, preservatives
SuspensionsSedimentation, caking, redispersibility, dose uniformitySuspending agents, wetting agents, flocculating agents
EmulsionsStability against creaming and cracking, choice of oil-in-water or water-in-oilEmulsifying agents selected using the HLB system
Ointments, creams and gelsSpreadability, drug release, skin feel, stabilityBases, emulsifiers, gelling agents, preservatives

Stokes' law shows that the settling velocity of suspended particles is proportional to the square of particle radius and to the density difference, and inversely proportional to viscosity. So halving the particle radius cuts the settling rate to a quarter, and doubling the viscosity halves it, which is why suspensions use fine particles and suspending agents. The hydrophilic-lipophilic balance (HLB) scale helps choose emulsifiers: lower values favour water-in-oil systems and higher values favour oil-in-water systems.

Sterile dosage forms: principles

Injections, eye drops and some other products must be sterile. At the level of principles, formulation students learn that such products must be:

  • Sterile, free from viable micro-organisms, achieved by terminal sterilisation where the product allows it or by aseptic processing
  • Free from pyrogens and particulate matter
  • Stable in solution or as a dry powder for reconstitution
  • Isotonic where appropriate, to avoid tissue damage and pain
  • Prepared in clean room environments under good manufacturing practice (GMP)

Excipients in sterile products are chosen carefully, for example tonicity agents, buffers, antioxidants and, for multi-dose containers, preservatives. Course work focuses on the reasoning behind these requirements and the relevant pharmacopoeial tests, not on preparing products, which only takes place under regulated conditions.

Where do pharmaceutical formulation students lose marks?

  • Choosing a dosage form without using the drug's properties.
  • Treating excipients as inert.
  • Omitting units, or not checking a calculation by a second route.
  • Listing tablet defects without their mechanisms.
  • Confusing dissolution with bioavailability.
  • Quoting stability conditions with no guideline cited.

Pharmaceutical formulation help at every level

LevelWhat you studyMatching help
D.Pharm and B.PharmPharmaceutics, dosage forms, industrial pharmacyHomework help and live tutoring
MPharm, PharmD and M.PharmFormulation science, modified release, stability, regulatory aspectsAssignment help
Industrial training and researchPreformulation studies, formulation development projectsDissertation help

Related: Pharmaceutics and Pharmacy.

Country notes: studying pharmaceutical formulation

  • India: pharmaceutics and industrial pharmacy are core B.Pharm and M.Pharm papers following Pharmacy Council of India syllabi, with Indian Pharmacopoeia tests and industrial training.
  • United Kingdom and Ireland: formulation science is part of MPharm and pharmaceutical science degrees, often with lab-based formulation projects and British Pharmacopoeia references.
  • United States and Canada: pharmaceutics courses in PharmD and pharmaceutical sciences programmes, using USP standards.
  • Gulf states, Singapore, Malaysia, Australia and New Zealand: pharmacy degrees following national regulators and the relevant pharmacopoeias.

Lessons follow your own syllabus, pharmacopoeia and lab manual, and are scheduled in your time zone.

How is pharmaceutical formulation taught and assessed in the UK, US, Australia, Europe, Singapore, Malaysia and the Gulf?

Formulation science is part of every pharmacy degree, but the length of the degree, the pharmacopoeia students quote and the licensing route vary. This is educational information about courses only.

RegionDegree routeHow formulation is assessedPharmacopoeia and regulators students cite
UK and IrelandFour-year MPharm accredited by the GPhC in Great Britain; five-year integrated MPharm in IrelandLab reports, formulation projects, calculation assessments and exams; UK degree classesBritish Pharmacopoeia, European Pharmacopoeia; MHRA in the UK
US and CanadaPharmD professional degrees; pharmaceutical sciences BS, MS and PhDExams and lab courses; GPA on a 4.0 scale; licensing exams after graduationUSP–NF; FDA in the US and Health Canada
Australia and New ZealandBachelor or master's degrees in pharmacy, then an intern yearPractical classes, reports and exams; High Distinction to PassTGA default standards include the BP, Ph. Eur. and USP; Medsafe in New Zealand
EU (ECTS)Pharmacy degrees regulated under EU rules on professional qualifications, usually five years including a traineeshipWritten and oral exams, lab practicals; national grade scalesEuropean Pharmacopoeia; EMA and national agencies
Singapore and MalaysiaFour-year pharmacy honours degreesLab work, projects and exams; CGPAHSA (Singapore); NPRA (Malaysia)
GCC (UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain)BPharm and PharmD programmes, often in EnglishExams, labs and projects; GPANational drug authorities such as the SFDA in Saudi Arabia, with USP and BP references
IndiaB.Pharm, M.Pharm and D.Pharm under PCI syllabiUniversity exams and practicalsIndian Pharmacopoeia; CDSCO

Wherever you study, ICH guidelines provide the shared language for stability and development work, which is why they appear in coursework in every region.

Who tutors pharmaceutical formulation, and which subjects connect to it?

Pharmaceutical formulation students are matched with tutors who hold a master's or PhD in pharmaceutics or pharmaceutical sciences and who have formulation laboratory or industry experience. Sessions use your own syllabus, lab manual and data, and stay at the level of science and coursework rather than patient treatment.

Formulation links to these subjects:

Your tutor explains and reviews; the lab reports, designs and answers you submit remain your own under your institution's rules.

How much does pharmaceutical formulation help cost?

Fees reflect the kind of support and how soon it is needed. A single calculation or concept costs less than feedback on a full formulation report. You see a fixed quote for written guidance, or the tutor's hourly rate for live lessons, before you decide, with no contract and no minimum booking. Refunds follow our refund policy.

Get a free pharmaceutical formulation quote.

Stuck on a Pharmaceutical Formulation question?

Send it to a Pharmaceutical Formulation tutor for step-by-step working. The quote is free.

What you get

Every Pharmaceutical Formulation order includes

  • Written from scratch to your exact brief
  • Fully referenced in your required citation style
  • Plagiarism-checked before delivery
  • Free revisions until you are satisfied
  • 100% confidential — your privacy protected
Free, unlimited
Revision policy

Simple process

How your Pharmaceutical Formulation help works

01

Describe your Pharmaceutical Formulation task

Tell us your assignment brief, word count, deadline, and academic level. The more detail, the better the match.

02

Matched to a specialist

We pair you with a Pharmaceutical Formulation expert whose background aligns with your specific topic and university requirements.

03

Delivered, checked, revised

Your work arrives before the deadline, plagiarism-checked. Free revisions until it meets your exact requirements.

Takes about two minutes. The quote is free.

Pharmaceutical Formulation and related specialists

Who handles your Pharmaceutical Formulation work

Every expert is degree-verified and quality-tested before joining.

  • Sumit Kumar

    S. Kumar

    VERIFIED
    Pharmacology & Pharmaceutical Sciences Expert

    I specialize in Pharmacology and Pharmaceutical Sciences, with a focus on Clinical Pharmacology, Drug Discovery and Development, Pharmacokinetics, Pharmacodynamics, and Toxicology. I help students understand complex pharmaceutical concepts through clear explanations and…

    • Drug Mechanism of Action Analysis
    • Pharmacological Data Interpretation
    • Pharmacokinetic Calculations
    • Pharmacodynamic Analysis
    15$/hr
    Rate
  • Divyanshi  sharma

    D. sharma

    VERIFIED
    Pharmacy & Pharmacology Expert

    I am passionate about making pharmacy and pharmacology easier to understand by connecting scientific concepts with practical healthcare applications. My teaching focuses on general pharmacology, clinical pharmacology, pharmacokinetics, pharmacodynamics, drug mechanisms of…

    • Pharmacological Analysis
    • Pharmacokinetic Calculations
    • Pharmacodynamic Analysis
    • Drug Mechanism Interpretation
    13$/hr
    Rate
  • Rahul Sani

    R. Sani

    VERIFIED
    Pharmacology Expert & Tutor

    Understanding how medicines work in the human body is essential for safe and effective healthcare. As a Pharmacology Tutor, I focus on helping students build a strong understanding of Clinical Pharmacology, Pharmacokinetics, Pharmacodynamics, Drug Mechanisms of Action, and…

    • Pharmacological Concept Analysis
    • Drug Mechanism Interpretation
    • Pharmacokinetic Calculations
    • Pharmacodynamic Analysis
    15$/hr
    Rate
  • Rohit Shukla

    R. Shukla

    VERIFIED
    Nursing Education Expert

    I am a nursing education tutor dedicated to helping students build strong foundations in nursing theory, clinical knowledge, and patient care. My teaching focuses on nursing fundamentals, medical-surgical nursing, anatomy & physiology, pharmacology, community health nursing, and…

    • Care Planning
    • Patient Care
    • Clinical Knowledge
    • Medication Safety
    15$/hr
    Rate

Student reviews

What students say about Pharmaceutical Formulation help

Used FLN Tutors? Be one of the first to share how it went, in writing or in a short video.

Pharmaceutical Formulation tutoring: frequently asked questions

What is pharmaceutical formulation?

Pharmaceutical formulation is the process of turning an active ingredient into a usable dosage form that delivers an accurate dose, stays stable for its shelf life, releases the drug appropriately, can be manufactured at scale, and is acceptable enough that patients will take it.

What is preformulation?

Preformulation is the characterisation of an active substance before a dosage form is designed, covering solubility and its pH dependence, pKa, lipophilicity, crystal form and polymorphism, particle size, stability and excipient compatibility. Every later formulation decision follows from these properties.

What are excipients?

Excipients are the components of a dosage form other than the active ingredient, including diluents, binders, disintegrants, lubricants, glidants, surfactants, preservatives and coatings. They are not inert filler: each has a defined function, and the quantity used affects both manufacturability and how the product performs.

What does a disintegrant do?

A disintegrant makes a tablet break apart into fine particles on contact with fluid, greatly increasing the surface area available for dissolution. Without an adequate disintegrant, a perfectly well-made and correctly dosed tablet can release its drug far too slowly to produce the intended effect.

Why can too much lubricant be a problem?

Lubricants are typically hydrophobic and coat particle surfaces to stop material sticking to tooling. In excess, that coating repels water, slowing wetting and dissolution. It is a standard example of an excipient fixing a manufacturing problem while creating a performance one.

What is polymorphism and why does it matter?

Polymorphism is the ability of a substance to crystallise in more than one structure. Different polymorphs can differ in solubility, dissolution rate and stability, so an unintended change in crystal form during manufacture or storage can alter how the product performs.

What causes tablet capping?

Capping, where the top separates as a cap, is generally caused by air trapped in the compact and by excessive compression force, sometimes worsened by poor binder or very fine powder. Remedies address air removal, pre-compression and reduced main compression force.

What is the difference between a formulation and a dosage form?

A dosage form is the physical type of product, such as a tablet, capsule, cream or injection. A formulation is the specific recipe and process inside it: the active, the chosen excipients, their proportions and the manufacturing steps. Two tablets of the same dosage form can have very different formulations and release profiles.

What is dissolution testing for?

Dissolution testing measures how quickly a drug enters solution under defined conditions. Since a drug must dissolve before it can be absorbed, dissolution is often the rate-limiting step for poorly soluble drugs, and it is used for quality control and for comparing formulations.

What is the difference between dissolution and bioavailability?

Dissolution is how fast and completely the drug goes into solution in a test apparatus. Bioavailability is the fraction of the dose that actually reaches the systemic circulation unchanged, which also depends on permeability and on first-pass metabolism, not on dissolution alone.

What is first-pass metabolism, and why does it matter for formulation?

First-pass metabolism is the breakdown of a drug by the gut wall and liver before it reaches the systemic circulation after oral administration. It can greatly reduce bioavailability, which is one reason some drugs are given by injection, sublingually or transdermally instead.

What is an enteric coating for?

An enteric coating resists gastric acid and dissolves in the more alkaline small intestine. It protects acid-labile drugs from degradation in the stomach, protects the stomach lining from irritant drugs, and can delay release until the drug reaches its intended site of absorption further along the gut.

How is drug stability tested?

Samples are stored under controlled temperature and humidity, both in real time and under accelerated conditions, and assayed over time for loss of active and for degradation products. The data support a shelf life and a storage statement, following the guideline applicable in the region.

What is w/v and how do I use it?

Weight in volume expresses grams of solute per hundred millilitres of solution, so a five per cent w/v solution contains five grams in every hundred millilitres. Keep units consistent and check dilution calculations by computing the mass of solute both before and after.

How much does pharmaceutical formulation help cost?

Pharmaceutical formulation help is quoted per task, so the price reflects the amount of work and your submission date. A single Carr's index or shelf-life question is brief, while reviewing a full formulation project or dissolution report takes longer. A free quote or session rate is shown before you commit.

What is Carr's index?

Carr's compressibility index measures how well a powder flows, calculated as tapped density minus bulk density, divided by tapped density, multiplied by 100. Lower values indicate better flow. For example, about 16 to 20 percent is usually classed as fair flow on the commonly used pharmacopoeial scale.

What is wet granulation?

Wet granulation is a tablet manufacturing method in which powders are mixed with a binder solution to form a wet mass, which is granulated, dried and sized. It improves flow, compressibility and uniformity of drug distribution, but the heat and moisture involved may not suit sensitive drugs.

What is friability in tablets?

Friability measures a tablet's resistance to chipping and abrasion during handling. Tablets are tumbled in a rotating drum, and the percentage weight loss is calculated. A mean weight loss of not more than 1 percent is a commonly used pharmacopoeial limit, although you should check your own pharmacopoeia.

What is a sustained release tablet?

A sustained release tablet releases its drug slowly over many hours, rather than all at once, so it can be taken less often and gives steadier blood levels. Common designs use hydrophilic matrix polymers, rate-controlling coatings or osmotic systems. Many such tablets should not be crushed or chewed.

What are ICH stability testing conditions?

The ICH Q1A guideline describes stability studies at defined temperature and humidity, such as long-term testing at 25 degrees Celsius and 60 percent relative humidity and accelerated testing at 40 degrees Celsius and 75 percent relative humidity for six months. Conditions depend on the climatic zone and product type.

Question not answered here?

Not sure which service you need?

Tell us your assignment brief and deadline — we'll match you with the right expert and service instantly.

Money-Back Guarantee

Full refund if we miss the agreed deadline, can't find a suitable expert, or major errors can't be fixed by revision.

Learn more →

100% Confidential

Your identity, order details and institution are never shared with any third party.

Learn more →

Deadline-Backed Delivery

Every order has an agreed deadline. If we don't deliver by it, you can claim a full refund.

Learn more →

Get started today

Ready to get expert help?

Tell us what you need and get matched with a tutor who teaches your subject. Delivered on time, every time.

See how it works
Instant quoteNo account needed to get a priceFree revisions100% confidential